Parallax Volatility Advisers’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SBH
Parallax Volatility Advisers's ANGO Position: Q3 2018 in Review
Parallax Volatility Advisers sold out of AngioDynamics (ANGO) in Q3 2018, closing a stake of 110 shares — an estimated $2K sold.
Parallax Volatility Advisers first reported a position in ANGO in Q4 2017 and held it in 2 quarters. The position peaked at $93K in Q4 2017. 177 funds tracked by Wall St. Rank hold ANGO as of Q3 2018.
- Parallax Volatility Advisers reported no remaining AngioDynamics position as of Q3 2018 after selling out during the quarter.
- Parallax Volatility Advisers sold 110 AngioDynamics shares in Q3 2018, an estimated $2K.
- Parallax Volatility Advisers first reported a position in AngioDynamics in Q4 2017 and held it in 2 quarters.
- Parallax Volatility Advisers's AngioDynamics position peaked at $93K in Q4 2017.
- 177 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2018.
Based on Parallax Volatility Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.